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Poster Session II S363the gastrointestinal tract and severe histopathology. The specific
deletion of recipient dendritic cells surprisingly enhanced the ex-
pansion of donor alloantigen-specific T cells and accelerated
GVHD mortality due to a failure of activation-induced donor
T cell death. Consistent with this, the use of bone marrow-chi-
meric recipients demonstrated that professional, hematopoietic-
derived recipient APC in isolation were limited in their capacity
to induce GVHD. In contrast, non-hematopoietic recipient APC
in isolation induced universal GVHD mortality with high levels
of alloreactive donor T cell expansion and inflammatory cytokine
generation. Confocal imaging demonstrated that MHC class II is
highly expressed in recipient non-hematopoietic tissue within the
dermis and intestinal villi. Donor T cell activation (CD69) and
memory differentiation (CD62Llo/CD44hi) occurred in irradiated
recipients in an antigen-independent fashion and resulted in the
acquisition of a memory cell phenotype and Th1 differentiation
in lymph nodes. Within 3 days after BMT, these donor T cells
began entering the GI tract and interacted with MHC class II+
non-hematopoietic cells leading to lethal acute GVHD.
Conclusion: These data challenge current paradigms, demon-
strating that lethal acute GVHD can be induced by alloantigen
presented solely within MHC class II by non-hematopoietic re-
cipient APC.430
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Oral chronic graft-versus-host disease (cGVHD) is a serious com-
plication of allogeneic stem cell transplantation, and may be the pri-
mary site of disease activity. Scales and instruments recently
introduced to measure severity and response to therapy have not
been prospectively validated. The objective of this study was to de-
scribe the characteristics of oral cGVHD and determine the mea-
sures most sensitive to change.
Methods:Patients enrolled in the cGVHD Consortium with oral
involvement were included. Clinicians scored oral cGVHD ac-
cording to the 2005 NIH criteria for severity scoring (0-3) and
response (erythema, lichenoid changes, ulcers, mucoceles), and
patients completed measures. Other evaluated measures included
the esophageal response measure, Hopkins mouth score, and
weight. Clinicians and patients also rated change on an 8-point
scale, categorized as improved (1-3), stable (4-6), or worsened
(7-8).
Results: Of 458 participants with cGVHD, 72% (n 5 331) had oral
cGVHD involvement at enrollment and were followed for a median
of 13.6 months (2.0-38.5). Lichenoid change was the most common
objective finding (n5 293; 89%), and 25%of patients had only lichen-
oid involvement. Oral cGVHDwas not associated with global quality
of life as measured by the FACT-BMT or SF-36. At visits where
change could be assessed (n 5 501, 52% of follow-up visits), 51% of
clinicians and 56%patients reported improvement, withworsening re-
ported in 4-5% for both groups; agreement between clinician and pa-
tient perceived change was fair (weighted kappa5 0.41), but only 1%
of visits had highly discordant changes (improve vs. worse). Multivari-
able regression modeling suggested that the serial measurement
changes most predictive of perceived change by clinicians and patients
were the erythema and lichenoid scores, NIH severity score, clinician
assessed pain score and patient assessed Lee oral symptom score. Serial
change in erythema and lichenoid features showed synergy, with more
combined impact than each feature alone. Perceived changes in oral
cGVHDwere not associated with change in ulcers, mucoceles, esoph-
ageal scores or patient weight.
Conclusions: Oral involvement in cGVHD is common and associ-
ated with a wide range of signs and symptoms that generally improve
with time. Measurement of oral erythema and lichenoid changes,
pain and patient symptoms using 6 questionsmay adequately capture
the activity of oral cGVHD in clinical trials.431
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Following allogeneic bone marrow transplantation (allo BMT),
patients are at high risk for developing intestinal inflammation sec-
ondary to graft-versus-host disease (GVHD). While the impact of
the microbiota on GVHD is known to be significant, no consensus
exists between BMT centers regarding the optimal approach to tar-
get the flora.
We first examined in mouse models the effects of GVHD on gut
flora. While BMT alone produced surprisingly few changes in the
flora of mice, with GVHD we observed loss of overall diversity,
and in particular expansion of Lactobacillales and loss of Clostri-
diales. We studied the effects of eliminating Lactobacillales from
the flora of mice prior to BMT using antibiotics and observed aggra-
vation of GVHD, while re-introducing the predominant species of
Lactobacillus mediated significant protection resulting in improved
survival. These results frommurinemodels suggest thatGVHDpro-
duces unique changes in the flora, and that changes induced by anti-
biotics can aggravate GVHD.
We then characterized gut flora of eight patients undergoing allo
BMT during onset of intestinal inflammation due to GVHD, com-
pared to ten patients without GVHD. We again found patterns of
loss of diversity, expansion of Lactobacillales, and loss of Clostri-
diales, mirroring our findings in mice. We also identified increased
microbial chaos early following allo BMT as a potential risk factor
for subsequent GVHD. Together, these data increase our apprecia-
tion for reciprocal regulation of inflammation and flora in the intes-
tine, and suggest that flora manipulation may improve outcomes for
allo BMT recipients.Table. Summary of GVHD-induced changes in themicrobiota
Mice HumansNo GVHD GVHD No GVHD GVHDFlora diversity no change decreased no change decreased
Lactobacillales no change increased no change increased
Clostridiales no change decreased no change decreased432
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Introduction: Minor histocompatibility antigens located on the Y-
chromosome (HYminors) are known to play a pivotal role in alloge-
neic hematopoietic cell transplantation (HCT) with female donor
and male recipient. Only a few HYminors are known.We identified
a new HYminor using reverse immunology where candidate minors
first were predicted using bioinformatics and afterwards confirmed
with standard immune laboratory techniques.
Methods: Patient/donor pairs with female donors and male patients
were high resolution HLA typed. Candidate HY minor epitopes lo-
cated in genes only expressed on the Y chromosome were found us-
ing the HLA-pan restrictor (http://www.cbs.dtu.dk/services/
HLArestrictor). Post nonmyeloablative conditioning HCT PBMCs
from the patients were thawed, stimulated with these peptides and
tested for cytokine produktion (TNF-a and IFN-g) after restimula-
tion using flow cytometri. Approximately 140 peptides were synthe-
sized per patient/donor pair and the test for cytokine production was
carried out using a matrix system.When positive cytokine responses
were found, the optimal peptide and the HLA-restriction were de-
termined by affinity assays and tetramerstaining. Cytotoxity was
demonstrated by staining for CD107a.
Results: A strong cytokine response on an 11-mere peptide located
in the UTY gene was found in a patient transplanted for follicular
